You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 24385-0075


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 24385-0075

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

24385-0075 Market Analysis and Financial Projection

Market Analysis and Price Projections for Drug NDC: 24385-0075

Understanding the NDC System

To analyze the market and price projections for a specific drug identified by its NDC (National Drug Code), it is crucial to understand the NDC system. The NDC is a unique 11-digit code assigned to each drug product, including the labeler code, product code, and package code. This system helps in tracking and pricing drugs accurately[2].

Drug Identification

The NDC 24385-0075 corresponds to a specific drug product, but the exact drug name and details are not provided in the sources. However, for the purpose of this analysis, let's assume it is a common over-the-counter (OTC) or prescription drug.

Pricing Mechanisms

Average Manufacturer Price (AMP) and Unit Rebate Amount (URA)

For drugs covered under the Medicaid Drug Rebate Program, the 340B ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure. This calculation is crucial for determining the final ceiling price charged to 340B covered entities[2].

Historical Pricing Data

Reviewing historical pricing data is essential for understanding price trends and potential future adjustments. For example, if we look at the pricing trends of similar drugs, we can observe patterns such as:

  • Price Fluctuations: Prices can fluctuate based on supply and demand, regulatory changes, and market competition. For instance, the price of Imatinib Mesylate (NDC 00378-2245) has shown a declining trend over recent months, from $0.66780 per unit in December 2024 to $0.50016 per unit in September 2024[1].

Regulatory Changes

Changes in regulatory policies can significantly impact drug pricing. Updates to the Medicaid Drug Rebate Program or new FDA guidelines can alter the pricing mechanisms and affect the market prices of drugs. For example, changes in the calculation of AMP and URA can directly influence the ceiling prices for covered outpatient drugs[2].

Market Demand and Competition

The demand for the drug and the level of competition in the market are key factors influencing pricing strategies. High demand and low competition can lead to higher prices, while increased competition, especially from generics or biosimilars, can stabilize or reduce prices.

  • Example from NSCLC Market: In the Non-Small Cell Lung Cancer (NSCLC) market, the introduction of immunotherapies and targeted therapies has significantly impacted pricing. Drugs like Keytruda, Opdivo, and Tecentriq, despite being premium-priced, face competition and see their prices influenced by market dynamics and regulatory approvals[4].

Technological Advancements

The adoption of AI and other technological advancements can reduce development and manufacturing costs, potentially leading to lower prices.

  • AI in Pharma: According to industry experts, the adoption of AI in standard operations in clinical development is expected to double in 2025. This could lead to more efficient drug development and lower costs, which might reflect in the pricing of drugs[3].

Market Size and Growth Projections

The US pharmaceutical market is projected to grow significantly, from $846.72 billion in 2022 to $1.28 trillion by 2030, with a Compound Annual Growth Rate (CAGR) of 5.36%. This growth is driven by factors such as rising pharmaceutical production capacity, greater approvals of generic drugs, and escalating R&D investments[2].

Price Projections for NDC 24385-0075

To project prices for the specific NDC 24385-0075, we need to consider the following factors:

Historical Pricing Data

If available, historical pricing data for this NDC or similar drugs can provide insights into price trends.

Regulatory Changes

Any upcoming regulatory changes that could affect the pricing mechanisms need to be considered.

Market Demand and Competition

The current demand for the drug and the level of competition in the market will significantly influence the price projections.

Technological Advancements

The impact of technological advancements, such as AI, on the development and manufacturing costs of the drug.

Example Calculation

Assuming the NDC 24385-0075 corresponds to a drug that is widely used but faces moderate competition, here is a hypothetical example of price projection:

  • AMP: $50 per unit
  • URA: $10 per unit
  • Package Size: 30 units
  • Case Pack Size: 10 packages

Using the formula for the 340B ceiling price: [ \text{340B Ceiling Price} = (\text{AMP} - \text{URA}) \times \text{Package Size} \times \text{Case Pack Size} ] [ \text{340B Ceiling Price} = (50 - 10) \times 30 \times 10 = \$12,000 ]

This calculation provides a baseline for the ceiling price, but actual market prices can vary based on various factors including market demand, competition, and regulatory changes.

Key Takeaways

  • Historical Data: Essential for understanding price trends.
  • Regulatory Changes: Can significantly impact pricing mechanisms.
  • Market Demand and Competition: Key factors influencing pricing strategies.
  • Technological Advancements: Can reduce costs and potentially lower prices.
  • Market Growth: The US pharmaceutical market is projected to grow significantly by 2030.

FAQs

Q: What is the NDC system, and how does it affect drug pricing? A: The NDC system is a unique coding system for drug products. It helps in tracking and pricing drugs accurately by providing a standardized way to identify each drug product.

Q: How are ceiling prices calculated for covered outpatient drugs? A: Ceiling prices are calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure, then adjusting for package size and case pack size.

Q: What role do technological advancements play in drug pricing? A: Technological advancements, such as AI, can reduce development and manufacturing costs, potentially leading to lower prices.

Q: How does market competition affect drug prices? A: High competition, especially from generics or biosimilars, can stabilize or reduce drug prices, while low competition can lead to higher prices.

Q: What are the projected growth trends for the US pharmaceutical market? A: The US pharmaceutical market is projected to grow from $846.72 billion in 2022 to $1.28 trillion by 2030, with a CAGR of 5.36%.

Sources

  1. DrugPatentWatch - Latest drug prices and trends for NDC 00378-2245.
  2. DrugPatentWatch - Market Analysis and Price Projections for Drugs: Understanding the NDC System.
  3. Intelligencia.ai - 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch.
  4. Drug-Dev.com - NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025.
  5. FDA.Report - NDC 24385-005 Oral Solution Good Neighbor Pharmacy Day Time.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.